October 20, 2014 9:54 AM ET

Pharmaceuticals

Company Overview of ACCU-BREAK Pharmaceuticals, Inc.

Company Overview

ACCU-BREAK Pharmaceuticals, Inc. develops and licenses pharmaceutical tablet technologies. The company offers bi-layer and tri-layer technologies, which are used to create tablets that are dividable by hand into accurate partial/smaller doses for patients to adjust their dose. Its technologies are used for single drug products, fixed and split combination drug products, standard and controlled release formulations, and incompatible drugs in human and veterinary medicines. The company has a strategic alliance agreement with Azopharma Development Group. ACCU-BREAK Pharmaceuticals, Inc. was formerly known as SoLapharm, Inc. and changed its name to ACCU-BREAK Pharmaceuticals, Inc. in April 2006....

1000 South Pine Island Road

Suite 430

Plantation, FL 33324

United States

Founded in 2001

Phone:

954-236-7351

Fax:

954-236-7271

Key Executives for ACCU-BREAK Pharmaceuticals, Inc.

President and General Counsel
Age: 58
Executive Chairman of the Board
Age: 69
Co-Founder
Age: 60
Executive Director
Age: 77
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Or-Ion Products, Inc. United States
Vanguard Pharmaceutical Corporation United States
Redox Pharmaceutical Corporation United States
AMRI Burlington, Inc. United States
The Daily Wellness Company United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCU-BREAK Pharmaceuticals, Inc., please visit www.accubreakpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.